| Factor Information | |
|---|---|
| Data ID | 3795 |
| Factor | MCH(pg) |
| Description | In the cyanotic patients, the hematocrit, blood and plasma viscosity were all elevated, and mean corpuscular volume and mean corpuscular hemoglobin were decreased compared to acyanotic controls. |
| Biomarker | NA |
| Classification | E2 (physiological factor - biochemical index) |
| Association | |
|---|---|
| Application | risk assessment |
| Objective | The aim of this study was to investigate the risk of contrast-induced nephropathy in the small group of patients with cyanotic heart disease prior to surgical repair. |
| p Value | 0.007 |
| Conclusion | In the cyanotic patients, the hematocrit, blood and plasma viscosity were all elevated, and mean corpuscular volume and mean corpuscular hemoglobin were decreased compared to acyanotic controls |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 707 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | TOF, PS/DORV, PS/TOF, PA/VSD, ES/PAD, ES/ccTGA, VSD, PS/TA, restrictive VSD/ASD, EM/other |
| Reference | |
|---|---|
| PMID | 10695534 |
| Year | 2000 |
| Title | Cyanotic nephropathy and use of non-ionic contrast agents during cardiac catherization in patients with cyanotic congenital heart disease |
| Sample | ||
|---|---|---|
| Population | children, adolescents and adults | |
| Source | Blood | |
| Region | Berlin,Germany | |
| Method | Blood viscosity was measured before and after cardiac catherization. | |
| Race | Europe | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | patients with Cyanotic heart disease(Treatment) | ASD controls(Control) |
| Number | 23 | 13 |
| Age | 25 (5-63) years | 37 (20-66) years |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 28.8 (20.3-32.7) pg | 30.7 (27.8-34) pg |
